Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from NanoVibronix ( (NAOV) ) is now available.
On June 4, 2025, NanoVibronix announced the appointment of Doron Besser as its new CEO following the retirement of Brian Murphy, who will remain on the board. This leadership transition coincides with the company’s strategic acquisition of ENvue, enhancing its growth potential and market positioning in the medical device sector.
More about NanoVibronix
NanoVibronix, Inc. is a medical technology company specializing in non-invasive and minimally invasive solutions for clinical and home care settings. The company focuses on acoustic-based therapeutic technologies, such as PainShield® and UroShield®, and the ENvue™ Navigation Platform, which assists in the placement of feeding tubes. Headquartered in Tyler, Texas, with R&D in Israel, NanoVibronix aims to advance standards in non-invasive therapy and navigation, emphasizing patient safety and technology innovation.
Average Trading Volume: 4,222,179
Technical Sentiment Signal: Sell
Current Market Cap: $2.92M
Find detailed analytics on NAOV stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue